BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25733330)

  • 1. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions.
    Hishikari K; Kimura S; Yamakami Y; Kojima K; Sagawa Y; Otani H; Sugiyama T; Kuwahara T; Hikita H; Takahashi A; Isobe M
    Atherosclerosis; 2015 Apr; 239(2):583-8. PubMed ID: 25733330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eicosapentaenoic acid levels predict prognosis of peripheral artery disease caused by aortoiliac artery lesions.
    Ito N; Hishikari K; Abe F; Kanno Y; Iiya M; Murai T; Hikita H; Takahashi A; Yonetsu T; Sasano T
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):263-268. PubMed ID: 33500105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).
    Takamura TA; Tsuchiya T; Oda M; Watanabe M; Saito R; Sato-Ishida R; Akao H; Kawai Y; Kitayama M; Kajinami K
    Atherosclerosis; 2017 Aug; 263():192-197. PubMed ID: 28651186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment.
    Murata N; Soga Y; Iida O; Yamauchi Y; Hirano K; Kawasaki D; Fujihara M; Tomoi Y
    Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):297-305. PubMed ID: 25524520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein and endovascular treatment of lower limb peripheral artery disease: an independent prognostic factor.
    Bleda S; de Haro J; Varela C; Acin F
    J Endovasc Ther; 2015 Apr; 22(2):233-9. PubMed ID: 25809368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cardiovascular disease: the Hisayama Study.
    Ninomiya T; Nagata M; Hata J; Hirakawa Y; Ozawa M; Yoshida D; Ohara T; Kishimoto H; Mukai N; Fukuhara M; Kitazono T; Kiyohara Y
    Atherosclerosis; 2013 Dec; 231(2):261-7. PubMed ID: 24267237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions.
    Dohi T; Iida O; Soga Y; Hirano K; Suzuki K; Takahara M; Uematsu M; Nanto S
    J Vasc Surg; 2014 Apr; 59(4):1009-1015.e1. PubMed ID: 24360237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease.
    Fujihara M; Fukata M; Odashiro K; Maruyama T; Akashi K; Yokoi Y
    Angiology; 2013 Feb; 64(2):112-8. PubMed ID: 22371626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease.
    Bernlochner I; Jaitner J; Fries V; Dommasch M; Mayer K; Ott I; Langwieser N; Fusaro M; Laugwitz KL; Kastrati A; Ibrahim T
    Vasa; 2016; 45(2):155-61. PubMed ID: 27058802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with peripheral arterial disease.
    Lee JH; Ko YG; Shin DH; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    J Vasc Surg; 2016 Mar; 63(3):756-63. PubMed ID: 26603545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease.
    Kanoh M; Inai K; Shinohara T; Tomimatsu H; Nakanishi T
    Heart Vessels; 2017 Dec; 32(12):1513-1522. PubMed ID: 28681101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions.
    Hiramori S; Soga Y; Iida O; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Ando K
    J Vasc Surg; 2017 Jun; 65(6):1690-1697. PubMed ID: 28268108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesion.
    Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Yokoi H; Uematsu M;
    J Vasc Surg; 2016 Dec; 64(6):1691-1695.e1. PubMed ID: 27575807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of 2-Year Mortality and Risk Stratification After Surgical or Endovascular Revascularization of Infrainguinal Artery Disease in Hemodialysis Patients With Critical Limb Ischemia.
    Shiraki T; Iida O; Takahara M; Soga Y; Mii S; Okazaki J; Kuma S; Yamaoka T; Kamoi D; Shintani Y; Ishikawa T; Kitano I; Uematsu M
    J Endovasc Ther; 2015 Oct; 22(5):719-24. PubMed ID: 26276552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio and Atherosclerotic Risk Factors in Patients With Peripheral Artery Disease.
    Nishibe T; Dardik A; Nishibe M; Kano M; Matsumoto R; Nakano Y; Maekawa K; Irikata Y; Ogino H; Ono S; Koizumi J
    Vasc Endovascular Surg; 2021 Feb; 55(2):112-116. PubMed ID: 33073735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia Increases Mortality After Open or Endovascular Treatment in Patients with Critical Limb Ischemia: A Retrospective Analysis.
    Velescu A; Clará A; Cladellas M; Peñafiel J; Mateos E; Ibañez S; Mellado M
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):543-9. PubMed ID: 26810343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Perioperative Complications After Endovascular Therapy in Diabetic Patients With Critical Limb Ischemia due to Isolated Infrapopliteal Lesions.
    Okamoto S; Iida O; Takahara M; Yamauchi Y; Hirano K; Soga Y; Suzuki K; Uematsu M
    J Endovasc Ther; 2016 Apr; 23(2):371-7. PubMed ID: 26874179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of perioperative complications after endovascular therapy in patients with peripheral artery disease due to femoropopliteal lesions.
    Sato K; Iida O; Takahara M; Soga Y; Suzuki K; Tanigawa T; Ito M; Uematsu M
    J Vasc Surg; 2015 May; 61(5):1272-7. PubMed ID: 25925540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease.
    Nagahara Y; Motoyama S; Sarai M; Ito H; Kawai H; Takakuwa Y; Miyagi M; Shibata D; Takahashi H; Naruse H; Ishii J; Ozaki Y
    Atherosclerosis; 2016 Jul; 250():30-7. PubMed ID: 27175609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.